3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde

C144H133BrN20O23 — CID 161228132

IUPAC3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde
SMILESC=CCBr.C=CCOc1ccc(C[C@H](NC(=O)c2cccnc2-n2ccc(-c3cccc(OCC=C)c3)n2)C(=O)OC)cc1.COC(=O)[C@@H]1Cc2ccc(cc2)OCC=CCOc2cccc(c2)-c2ccn(n2)-c2ncccc2C(=O)N1.COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccnc1-n1ccc(-c2cccc(O)c2)n1.O=C1N[C@H](CO)Cc2ccc(cc2)OC/C=C/COc2cccc(c2)-c2ccn(n2)-c2ncccc21.O=C[C@@H]1Cc2ccc(cc2)OC/C=C/COc2cccc(c2)-c2ccn(n2)-c2ncccc2C(=O)N1
InChIInChI=1S/C31H30N4O5.C29H26N4O5.C28H26N4O4.C28H24N4O4.C25H22N4O5.C3H5Br/c1-4-18-39-24-13-11-22(12-14-24)20-28(31(37)38-3)33-30(36)26-10-7-16-32-29(26)35-17-15-27(34-35)23-8-6-9-25(21-23)40-19-5-2;1-36-29(35)26-18-20-9-11-22(12-10-20)37-16-2-3-17-38-23-7-4-6-21(19-23)25-13-15-33(32-25)27-24(28(34)31-26)8-5-14-30-27;2*33-19-22-17-20-8-10-23(11-9-20)35-15-1-2-16-36-24-6-3-5-21(18-24)26-12-14-32(31-26)27-25(28(34)30-22)7-4-13-29-27;1-34-25(33)22(14-16-7-9-18(30)10-8-16)27-24(32)20-6-3-12-26-23(20)29-13-11-21(28-29)17-4-2-5-19(31)15-17;1-2-3-4/h4-17,21,28H,1-2,18-20H2,3H3,(H,33,36);2-15,19,26H,16-18H2,1H3,(H,31,34);1-14,18,22,33H,15-17,19H2,(H,30,34);1-14,18-19,22H,15-17H2,(H,30,34);2-13,15,22,30-31H,14H2,1H3,(H,27,32);2H,1,3H2/b;;2*2-1+;;/t28-;26-;3*22-;/m00000./s1
InChIKeyUYJVXMXOTWNQFY-MHRKEPMVSA-N
MW2591.67 g/mol
LogP20.18
Rot. Bonds24

About 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde

3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde (PubChem CID 161228132) has the molecular formula C144H133BrN20O23 and a molecular weight of 2591.67 g/mol. Its IUPAC name is 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde.

Molecular Properties

Compound Name3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde
PubChem CID161228132
Molecular FormulaC144H133BrN20O23
Molecular Weight2591.67 g/mol
Exact Mass2588.90
IUPAC Name3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde
SMILESC=CCBr.C=CCOc1ccc(C[C@H](NC(=O)c2cccnc2-n2ccc(-c3cccc(OCC=C)c3)n2)C(=O)OC)cc1.COC(=O)[C@@H]1Cc2ccc(cc2)OCC=CCOc2cccc(c2)-c2ccn(n2)-c2ncccc2C(=O)N1.COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccnc1-n1ccc(-c2cccc(O)c2)n1.O=C1N[C@H](CO)Cc2ccc(cc2)OC/C=C/COc2cccc(c2)-c2ccn(n2)-c2ncccc21.O=C[C@@H]1Cc2ccc(cc2)OC/C=C/COc2cccc(c2)-c2ccn(n2)-c2ncccc2C(=O)N1
InChIInChI=1S/C31H30N4O5.C29H26N4O5.C28H26N4O4.C28H24N4O4.C25H22N4O5.C3H5Br/c1-4-18-39-24-13-11-22(12-14-24)20-28(31(37)38-3)33-30(36)26-10-7-16-32-29(26)35-17-15-27(34-35)23-8-6-9-25(21-23)40-19-5-2;1-36-29(35)26-18-20-9-11-22(12-10-20)37-16-2-3-17-38-23-7-4-6-21(19-23)25-13-15-33(32-25)27-24(28(34)31-26)8-5-14-30-27;2*33-19-22-17-20-8-10-23(11-9-20)35-15-1-2-16-36-24-6-3-5-21(18-24)26-12-14-32(31-26)27-25(28(34)30-22)7-4-13-29-27;1-34-25(33)22(14-16-7-9-18(30)10-8-16)27-24(32)20-6-3-12-26-23(20)29-13-11-21(28-29)17-4-2-5-19(31)15-17;1-2-3-4/h4-17,21,28H,1-2,18-20H2,3H3,(H,33,36);2-15,19,26H,16-18H2,1H3,(H,31,34);1-14,18,22,33H,15-17,19H2,(H,30,34);1-14,18-19,22H,15-17H2,(H,30,34);2-13,15,22,30-31H,14H2,1H3,(H,27,32);2H,1,3H2/b;;2*2-1+;;/t28-;26-;3*22-;/m00000./s1
InChIKeyUYJVXMXOTWNQFY-MHRKEPMVSA-N
XLogP20.18
TPSA529.55 Ų
H-Bond Donors8
H-Bond Acceptors38
Rotatable Bonds24
Heavy Atoms188
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002591.67
LogP ≤ 520.18
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde?
The IUPAC name of 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde (CID 161228132) is 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde.
What is the SMILES notation for 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde?
The canonical SMILES for 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde is C=CCBr.C=CCOc1ccc(C[C@H](NC(=O)c2cccnc2-n2ccc(-c3cccc(OCC=C)c3)n2)C(=O)OC)cc1.COC(=O)[C@@H]1Cc2ccc(cc2)OCC=CCOc2cccc(c2)-c2ccn(n2)-c2ncccc2C(=O)N1.COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccnc1-n1ccc(-c2cccc(O)c2)n1.O=C1N[C@H](CO)Cc2ccc(cc2)OC/C=C/COc2cccc(c2)-c2ccn(n2)-c2ncccc21.O=C[C@@H]1Cc2ccc(cc2)OC/C=C/COc2cccc(c2)-c2ccn(n2)-c2ncccc2C(=O)N1.
What is the InChIKey of 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde?
The InChIKey is UYJVXMXOTWNQFY-MHRKEPMVSA-N. The full InChI is InChI=1S/C31H30N4O5.C29H26N4O5.C28H26N4O4.C28H24N4O4.C25H22N4O5.C3H5Br/c1-4-18-39-24-13-11-22(12-14-24)20-28(31(37)38-3)33-30(36)26-10-7-16-32-29(26)35-17-15-27(34-35)23-8-6-9-25(21-23)40-19-5-2;1-36-29(35)26-18-20-9-11-22(12-10-20)37-16-2-3-17-38-23-7-4-6-21(19-23)25-13-15-33(32-25)27-24(28(34)31-26)8-5-14-30-27;2*33-19-22-17-20-8-10-23(11-9-20)35-15-1-2-16-36-24-6-3-5-21(18-24)26-12-14-32(31-26)27-25(28(34)30-22)7-4-13-29-27;1-34-25(33)22(14-16-7-9-18(30)10-8-16)27-24(32)20-6-3-12-26-23(20)29-13-11-21(28-29)17-4-2-5-19(31)15-17;1-2-3-4/h4-17,21,28H,1-2,18-20H2,3H3,(H,33,36);2-15,19,26H,16-18H2,1H3,(H,31,34);1-14,18,22,33H,15-17,19H2,(H,30,34);1-14,18-19,22H,15-17H2,(H,30,34);2-13,15,22,30-31H,14H2,1H3,(H,27,32);2H,1,3H2/b;;2*2-1+;;/t28-;26-;3*22-;/m00000./s1.
What are the key properties of 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde?
3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde has a molecular weight of 2591.67 g/mol, XLogP of 20.18, 24 rotatable bonds, 8 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromoprop-1-ene;(3S,23E)-3-(hydroxymethyl)-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaen-5-one;methyl (2S)-3-(4-hydroxyphenyl)-2-[[2-[3-(3-hydroxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;methyl (3S)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carboxylate;methyl (2S)-3-(4-prop-2-enoxyphenyl)-2-[[2-[3-(3-prop-2-enoxyphenyl)pyrazol-1-yl]pyridine-3-carbonyl]amino]propanoate;(3S,23E)-5-oxo-21,26-dioxa-4,10,12,33-tetrazapentacyclo[25.2.2.112,15.116,20.06,11]tritriaconta-1(30),6(11),7,9,13,15(33),16(32),17,19,23,27(31),28-dodecaene-3-carbaldehyde is sourced from PubChem (CID 161228132), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).